MVP™ MVP-7Q (UDI 00763000702106)Recalls & reported problems
Medtronic, Inc. · PLUG MVP-7Q MICRO VASCULAR · Class 2 · Implant
All models of MVP (13)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00763000702106), received between Mar 27, 2024 and Feb 23, 2026 — classified as 2 injuries, 1 malfunction.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Detachment of Device or Device Component2
- Activation, Positioning or Separation Problem1
- Difficult to Remove1
- Migration or Expulsion of Device1
- Positioning Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryFeb 23, 2026Migration or Expulsion of Device
IT WAS REPORTED THAT EMBOLIZATION WAS PERFORMED USING AN MVP-3Q MICRO VASCULAR PLUG ON THE RIGHT HEPATIC ARTERY AND TWO ADDITIONAL MVP-7QS WERE USED FOR THE LEFT SIDE. THE EMBOLIZATION WAS CARRIED OUT IN COMBINATION WITH AN IMPLANTATION OF A CHEMOTHERAPY PUMP, TO SELECTIVELY TREAT LIVE TUMORS IN A PATIENT WITH A HISTORY OF CANCER. 2 DAYS POST-OP, ONE OF THE MVPS MIGRATED, WHICH RENDERED THE CHEMOTHERAPY PUMP NON-THERAPEUTIC AND NECESSITATED A NEW EMBOLIZATION PROCEDURE. DURING THE REINTERVENTION, THE MIGRATED MVP DEVICE WAS REMOVED, COILS WERE ADDED, AND A NEW MVP-7Q DEVICE WAS IMPLANTED. THE PATIENT WAS REPORTED TO BE ALIVE WITH NO FURTHER PATIENT INJURY REPORTED. ADDITIONAL INFORMATION 23-FEB-2026: THE MVP PLUG WAS SOAKED IN HEPARINIZED SALINE PRIOR TO USE. THE CATHETER WAS FLUSHED BEFORE INSE RTING THE PLUG. A CONTINUOUS FLUSH WAS MAINTAINED DURING THE PROCEDURE. SEVERAL DIFFERENT UNKNOWN SHEATHS HAVE BEEN TRIED UNTIL REACHING TARGET SITE. THE TARGET VESSEL DIAMETER WAS REPORTED AS 5.3MM. IT WAS REPORTED THAT THE ANATOMY WAS DIFFICULT AND TORTUOUS TO REACH TARGET SITE. HOWEVER, LANDING ZONE WAS VERY STRAIGHT. THE PLUG DID FULLY OPEN IN THE TARGET VESSEL BEFORE DETACHING, INCLUDI
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24412580 ↗InjuryFeb 5, 2026Activation, Positioning or Separation Problem; Detachment of Device or Device Component; Positioning Problem
IT WAS REPORTED THAT DURING A PROCEDURE INVOLVING THE PLUG MICRO VASCULAR MVP-7Q, THE MVP PLUG COULD NOT DETACH AS INTENDED DESPITE MULTIPLE ATTEMPTS TO ROTATE IT ANTICLOCKWISE. AFTER SEVERAL ATTEMPTS, THE PLUG DETACHED FROM THE DELIVERING WIRE, BUT THE DELIVERING WIRE ACCIDENTALLY GOTTEN STUCK WITH THE PLUG. THE PLUG WAS THEN ACCIDENTALLY PULLED BACK AND FELL INTO THE ANEURYSM SAC. THE PLUG WAS RETRIEVED SUCCESSFULLY BY SNARE, AND THE PROCEDURE WAS COMPLETED WITH A REPLACEMENT MVP PLUG OF THE SAME SIZE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24266183 ↗MalfunctionMar 27, 2024Difficult to Remove; Detachment of Device or Device Component; Difficult to Remove; Detachment of Device or Device Component
PHYSICIAN ATTEMPTED TO USE AN MVP-7Q DEVICE DURING TREATMENT OF A 10MM LESION THE PATIENT¿S LEFT MID PULMONARY ARTERY. MODERATE VESSEL TORTUOSITY AND MINIMAL VESSEL CALCIFICATION WERE REPORTED. LESION EXHIBITED NO STENOSIS. ARTERY DIAMETER REPORTED AS 5.5MM. THERE WERE NO ABNORMALITIES REPORTED IN RELATION TO ANATOMY. THERE WAS NO DAMAGE NOTED TO PACKAGING, I.E. SHELF CARTON, HOOP/TRAY. THERE WERE NO ISSUES NOTED WHEN REMOVING THE DEVICE FROM THE HOOP TRAY. THE IFU (INSTRUCTION FOR USE) WAS FOLLOWED DURING PREPARATION, PROCEDURE, POST-PROCEDURE WITHOUT ISSUE. THE MVP PLUG WAS SOAKED IN HEPARINIZED SALINE PRIOR TO USE. THE CATHETER WAS FLUSHED BEFORE INSERTING THE PLUG. A CONTINUOUS FLUSH WAS NOT MAINTAINED DURING THE PROCEDURE AS THE PATIENT WAS AN INFANT. THE DEVICE WAS NOT PASSED THROUGH A PREVIOUSLY DEPLOYED STENT. THE INNER DIAMETER SIZE OF CATHETER USED FOR DELIVERY WAS 6F. IT WAS REPORTED THE MVP DETACHED IN THE DELIVERY CATHETER. REMOVAL DIFFICULTIES WERE ALSO REPORTED. NO VESSEL DAMAGE REPORTED. THE DEVICE WAS SAFELY REMOVED FROM PATIENT. A REPLACEMENT MVP-7Q WAS USED TO COMPLETE PROCEDURE. NO PATIENT INJURY REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18985594 ↗
Other Device, Vascular, for Promoting Embolization devices
- POD RBYPOD8-APenumbra, Inc. · Device, Vascular, For Promoting Embolization195 reports
- CEREPAKTM MDH1Cerenovus, Inc. · Device, Vascular, for Promoting Embolization1 recall72 reports
- Azur CX Detachable 45-750824Microvention, Inc. · Device, Vascular, for Promoting Embolization115 reports
- Tornado G08261Cook Incorporated · Device, Vascular, for Promoting Embolization2 recalls7 reports
- Optima Coil System OPTI0930CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0720CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0413CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
- Prestige Coil System PRES0520HPKPLBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page